Table of Contents

A patent infringement analysis Osaka litigators can rely on has to be scoped for how western Japan actually enforces patents — before the Osaka District Court, one of only two courts in the country with first-instance jurisdiction over patent infringement, and the exclusive forum for disputes rooted in the Osaka, Hiroshima, Fukuoka and Takamatsu high-court regions. Osaka is the commercial capital of the Kansai region, a dense heartland of chemicals, materials and electronics that is home to Panasonic in Kadoma, Sharp in Sakai, Daikin in Kita-ku, and the Doshomachi pharmaceutical quarter where Takeda, Shionogi, Sumitomo Pharma and Ono trace their roots. The patents asserted here read on formulations, air-conditioning and display technology, semiconductors, specialty chemicals and materials, and every case turns on evidence that the accused product actually practises the claim. PerspireIP builds the claim charts and evidence-of-use that prove — or defeat — that link.
Where a patent infringement analysis Osaka case is decided
Japan channels every patent infringement suit through just two courthouses. Only the Tokyo District Court and the Osaka District Court hold first-instance jurisdiction over patent infringement litigation: Tokyo covers eastern Japan, and Osaka covers the west. Under the Code of Civil Procedure, if the defendant’s domicile, the plaintiff’s domicile in a damages claim, or the place of the infringing act falls within the district of a western high court — Osaka, Hiroshima, Fukuoka or Takamatsu — the Osaka District Court has exclusive first-instance competence. For any dispute anchored in the Kansai industrial base, Osaka is the venue.
The Osaka District Court runs two dedicated intellectual property divisions, staffed by judges who hear patent cases and supported by technical advisors (chosakan) who brief the bench on the science behind each claim. Cases are heard by collegial panels rather than a single judge, and the divisions manage a technically demanding docket in chemicals, electronics, machinery and pharmaceuticals. An adverse first-instance judgment is appealed not to a regional high court but to the specialist Intellectual Property High Court in Tokyo, which sits as the single second-instance forum for every Japanese patent appeal, whether the case started in Osaka or Tokyo.
- Osaka District Court — two IP divisions — the exclusive first-instance forum for patent infringement in western Japan, with collegial panels and technical advisors
- Tokyo District Court — the parallel first-instance forum for eastern Japan; the two courts split the country
- Intellectual Property High Court (Tokyo) — the single specialist appellate court for all Japanese patent judgments
- Japan Patent Office (JPO) — grants the Japanese patents being enforced and runs the separate invalidation-trial track
The double track: JPO invalidation trial and Article 104-3
The fact that reshapes strategy in every Osaka case is Japan’s double-track validity system. A patent’s validity can be attacked by two routes at once. The first is a trial for invalidation (mukou shinpan) filed at the JPO under Article 123 of the Patent Act, heard by a panel of appeal examiners in the Trial and Appeal Department, with any appeal going to the Intellectual Property High Court. The second is an invalidity defence raised inside the infringement suit itself before the Osaka District Court, under Article 104-3 of the Patent Act.
Article 104-3 codifies the Supreme Court’s landmark Kilby decision of 11 April 2000. The Court held that asserting a patent that clearly contained grounds for invalidation was an abuse of rights; the 2004 legislation turned that holding into a statutory defence and, crucially, dropped the requirement that the invalidity be “obvious.” Today the provision reads that where a patent “is recognised as one that should be invalidated by a trial for patent invalidation,” the patentee may not enforce it against the accused party. The infringement court can therefore decide validity for itself, without waiting for the JPO.
For an infringement analysis this is decisive. An accused party in Osaka can run both tracks in parallel — a JPO invalidation trial and an Article 104-3 defence — while a patentee must build a claim chart that survives an invalidity attack mounted in the same proceeding. Infringement and validity are effectively litigated together, so the mapping that shows the accused product reads on the claim has to be constructed alongside the prior-art position from day one, not after.
Osaka’s Kansai industries and the patents they assert
Osaka’s litigation profile is written by the Kansai industrial base clustered around it. The region is one of Japan’s densest concentrations of chemicals, materials and specialty manufacturing, and the asserted claims read on polymers, coatings, electronic materials, catalysts and production processes. These cases demand infringement be proven against a specific commercial product or process — a marketed grade, a manufacturing line, a formulation — rather than asserted in the abstract, which is exactly where an element-by-element claim chart earns its keep.
The second stream is electronics and machinery. Panasonic is headquartered in Kadoma, Sharp in Sakai, and Daikin — the global air-conditioning leader — in Kita-ku, Osaka. Their patents cover displays, batteries, semiconductors, connected devices, compressors and refrigeration systems, where infringement turns on teardowns, reverse-engineering of firmware and protocols, and analysis of how a device actually functions. Because so many manufacturers are headquartered in and around Osaka, the western-Japan docket is heavy with hardware and electronics disputes.
The third stream is pharmaceuticals, and it is historic. Osaka’s Doshomachi district has been Japan’s “medicine town” since the Edo period, and it remains the home base of Takeda, Shionogi, Sumitomo Pharma and Ono Pharmaceutical. Pharma claims read on formulations, salts and polymorphs, dosage regimens and manufacturing processes, and generic-versus-originator battles land squarely in the Osaka IP divisions. Whether the technology is a specialty chemical, an air-conditioning compressor, a display panel or a polymorph, the commercial question is identical: does the accused product fall within the scope of the asserted claim? Answering it is what an infringement analysis does.
Evidence, document production and claim scope in Japan
Japan has no broad US-style discovery, so building the evidence behind an infringement analysis is a more deliberate exercise — and that makes the analysis itself more important, not less. A patentee typically assembles its case from product teardowns, laboratory analysis, technical datasheets, published specifications and marketed-product evidence before suit, because it cannot rely on obtaining the other side’s internal documents by default. The claim chart has to stand largely on what the patentee can prove for itself.
Where the accused technology is hidden, the Patent Act and the Code of Civil Procedure offer targeted tools. A court can order document production of materials needed to prove infringement or calculate damages, and can appoint a neutral expert for an in-camera inspection under the reformed system that lets a court-appointed expert enter the alleged infringer’s premises and examine a process while protecting trade secrets. Article 105-2 and related provisions also allow the court to require the accused party to specify concretely how its product differs from the asserted claim, shifting the burden once the patentee has made a credible showing.
Every one of these mechanisms is only as strong as the claim mapping behind it. A judge asked to order production or an inspection needs a clear, limitation-by-limitation account of why the accused product plausibly reads on the claim, and a court weighing an Article 104-3 defence needs the infringement read and the validity position side by side. That mapping is the deliverable, and it has to be ready before the complaint is filed.
Claim charts and evidence-of-use that win in the Osaka District Court
Whether you are asserting a patent or defending against one, a western-Japan case is won or lost on a single document: the claim chart that maps each element of the asserted claim onto the accused product or process. Before the Osaka IP divisions the panel expects that mapping to be concrete — tied to the marketed chemical grade, the compressor, the display module or the pharmaceutical formulation — and supported by evidence-of-use that withstands the technical advisor’s scrutiny and any Article 104-3 invalidity defence raised in the same suit.
- Element-by-element claim charts mapping every limitation of the asserted claim to the accused product or process
- Evidence-of-use built from product teardowns, laboratory analysis, technical datasheets, regulatory dossiers and public technical literature
- Doctrine-of-equivalents analysis to the Japanese five-requirement (Ball Spline) test where the accused product is not a literal match
- Non-infringement and freedom-to-operate positions for an accused Kansai manufacturer, with claim construction pinned to the file wrapper and prosecution history
- A package scoped to the forum — an Osaka District Court complaint, a document-production motion, or the evidence base paired with a JPO invalidation trial
The analysis cuts both ways. For a patentee it converts a suspicion into a pleadable infringement case and anchors the damages claim. For an accused chemicals, electronics or pharmaceutical company it builds the non-infringement read that keeps a product on the market and frames the invalidity defence that runs, on the double track, in both the court and the JPO. Either way the decisive input is a rigorous, evidence-backed claim chart — not a conclusion asserted without proof.
How PerspireIP builds an Osaka infringement-analysis file
Every engagement follows the same disciplined path. We construct the claim scope first, fixing the correct construction from the claims, specification and prosecution history, then map each element against the real accused product or process. For chemicals and materials we work from marketed grades, analytical data and process evidence; for electronics and machinery from teardowns, firmware and protocols; for pharma from formulations, polymorph data and regulatory dossiers — charting infringement literally and, where needed, under the Japanese doctrine of equivalents.
- Claim construction and element-by-element charting to Japanese Patent Act standards, with the prosecution history in view
- Evidence-of-use assembly — teardowns, lab analysis, datasheets, regulatory and public technical sources — dated and documented to support a document-production motion
- Infringement and non-infringement positions built for either side of an Osaka District Court dispute
- Prior-art and invalidity mapping to support or defeat an Article 104-3 defence and a parallel JPO invalidation trial
- Deliverables scoped to your forum: a first-instance complaint before the Osaka IP divisions, or the evidence base for the double-track validity fight
We work alongside your Japanese benrishi and litigation counsel as a specialist analysis partner, deliver to Osaka District Court deadlines, and keep every engagement confidential. Whether you are a chemicals, electronics, materials or pharmaceutical company enforcing a patent, an accused party clearing a path to market, or counsel preparing a complaint or a defence, we scale to fit — a single claim chart, a multi-patent matter or ongoing portfolio support. Send us the patent number and the accused product, and we will scope a patent infringement analysis Osaka project within one business day.
IP Landscape & Resources in Osaka
Key intellectual-property authorities and venues relevant to Osaka:
- Japan Patent Office (JPO) — the national office that grants Japanese patents and runs the Article 123 trial for invalidation that forms one half of Japan's double-track validity system
- Courts in Japan — the official portal of the Japanese judiciary, including the Osaka District Court whose IP divisions hold exclusive first-instance jurisdiction over patent infringement in western Japan
- Intellectual Property High Court — the specialist court in Tokyo that hears every appeal from Osaka and Tokyo District Court patent judgments and from JPO invalidation trials
- World Intellectual Property Organization (WIPO) — publishes the patent judicial guide describing Japan's two-court first-instance structure and the Article 104-3 invalidity defence
Request a Patent Infringement Analysis in Osaka
Request a Patent Infringement Analysis in Osaka
Get claim-chart mapping and evidence-of-use built for the Osaka District Court’s IP divisions — for a first-instance complaint, a document-production motion, or the double-track validity fight across the court and the JPO. Send us the patent number and the accused product, and we will scope the work within one business day.
Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.
Frequently Asked Questions
Which court hears a patent infringement case in Osaka?
Japan gives first-instance jurisdiction over patent infringement to only two courts: the Tokyo District Court for eastern Japan and the Osaka District Court for the west. Where the defendant’s domicile, the plaintiff’s domicile in a damages claim, or the place of infringement lies within the Osaka, Hiroshima, Fukuoka or Takamatsu high-court regions, the Osaka District Court has exclusive first-instance competence. It runs two specialised intellectual property divisions with collegial panels and technical advisors who brief the judges on the science. An adverse judgment is appealed to the specialist Intellectual Property High Court in Tokyo, the single appellate forum for every Japanese patent case.
What is the difference between a JPO invalidation trial and an Article 104-3 defence?
They are the two lanes of Japan’s double-track validity system. A trial for invalidation (mukou shinpan) is filed at the Japan Patent Office under Article 123 and decided by a panel of appeal examiners, with appeal to the IP High Court. An Article 104-3 defence is raised inside the infringement suit itself, letting the Osaka District Court decide validity for that case. Article 104-3 codified the Supreme Court’s 2000 Kilby decision and dropped the requirement that the invalidity be obvious. An accused party can run both routes in parallel, so the infringement analysis has to sit alongside a prior-art position from the outset.
Where does an appeal from the Osaka District Court go?
Unlike ordinary civil appeals, a patent appeal does not go to a regional high court. Every appeal from an Osaka District Court patent infringement judgment goes to the Intellectual Property High Court in Tokyo, the single specialist appellate court established in 2005. The same court hears appeals from Tokyo District Court patent cases and from JPO invalidation trials, which concentrates Japanese patent doctrine in one bench. Because the IP High Court can review both the infringement finding and any validity determination, the claim chart and prior-art analysis built for the Osaka trial must be strong enough to survive a specialist second look.
Why is Osaka an important venue for chemicals, electronics and pharma patent disputes?
Osaka is the commercial heart of the Kansai region, one of Japan’s densest bases of chemicals, materials and electronics. Panasonic is headquartered in Kadoma, Sharp in Sakai and Daikin in Kita-ku, so display, battery, semiconductor and air-conditioning patents feature heavily on the western-Japan docket. Osaka’s Doshomachi district has been Japan’s medicine town since the Edo period and remains the home of Takeda, Shionogi, Sumitomo Pharma and Ono. Each dispute, whether over a specialty chemical, a compressor or a polymorph, turns on a concrete claim chart proving the accused product reads on the asserted claim.